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Background: There are increasing evidences on the role of non-coding RNA (ncRNA) as key regulator of cellular
homeostasis. LOC284889 is an uncharacterized ncRNA gene on reverse strand to MIF mapped to 22q11.23. MIF, a
lymphokine, regulates innate immune response by up-regulating the expression of TLR4, suppressing the p53
activity and has been shown to be involved in malaria pathogenesis.
Methods: In this study, the possible effect of MIF variations on malaria susceptibility was investigated by re-
sequencing the complete MIF gene along with 1 kb each of 5′ and 3′ region in 425 individuals from malaria
endemic regions of the Orissa and Chhattisgarh states of India. The subjects comprised of 160 cases of severe
malaria, 101 of mild malaria and 164 ethnically matched asymptomatic controls. Data were statistically compared
between cases and controls for their possible association with Plasmodium falciparum malarial outcome.
Results: It is the first study, which shows that the allele A (rs34383331T > A) in ncRNA is significantly associated with
increased risk to P. falciparum malaria [severe: OR = 2.08, p = 0.002 and mild: OR = 2.09, P = 0.005]. In addition, it has
been observed that the higher MIF-794CATT repeats (>5) increases malaria risk (OR = 1.61, p = 0.01). Further,
diplotype (MIF-794CATT and rs34383331T > A) 5 T confers protection to severe malaria (OR = 0.55, p = 0.002) while 6A
(OR = 3.07, p = 0.001) increases malaria risk.
Conclusions: These findings support the involvement of ncRNA in malarial pathogenesis and further emphasize
the complex genetic regulation of malaria outcome. In addition, the study shows that the higher MIF-794CATT
repeats (>5) is a risk factor for severe malaria. The study would help in identifying people who are at higher risk to
malaria and adapt strategies for prevention and treatment.
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Malaria is one of the most common infectious disease,
endemic in 104 countries [1], is caused by a protozoan
parasites of the genus Plasmodium. The most serious
form of disease is caused by Plasmodium falciparum.
According to WHO [1], there were 219 million inci-
dence of malaria in the year 2010 and an estimated
660,000 deaths worldwide. Malaria mortality is higher in
children worldwide and malarial resistance genes serves
as strongest know force for recent evolutionary selection* Correspondence: thangs@ccmb.res.in
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reproduction in any medium, provided the orin human genome, since first human started moving out
of Africa [2]. Various population-specific natural genetic
defense mechanisms have evolved in malaria-endemic
regions [3], such as sickle cell trait, glucose-6-phosphate
dehydrogenase deficiency, β-thalassaemia, duffy pheno-
types; which are maintained in endemic populations by
balancing selection [4,5]. The genetic basis of malaria re-
sistance and susceptibility is complex in many ways as
several genes have been found to be involved along with
environmental and parasite genetic factors. Studies have
confirmed that besides environmental factors and popu-
lation diversity, polymorphisms in innate immunity
genes such as Toll-like receptors (TLR2, TLR4, TLR9),
chemokines, and cytokines as well as the heterogeneity. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Table 1 Characteristics of studied subjects segregated
according to clinical classification
Sample size Mean age
(year) ± SD
Male: Female
Severe malaria 160 27.55 ± 12.34 92:68
Mild malaria 101 30.24 ± 15.71 67:34
Asymptomatic control 164 29.87 ± 19.53 92:72
Jha et al. Malaria Journal 2013, 12:345 Page 2 of 9
http://www.malariajournal.com/content/12/1/345in other immune-regulatory genes modulate malaria
pathogenicity [6-11].
Among various effector molecules, cytokines plays
crucial role as it speeds up the host inflammatory res-
ponses and coordinates the cell-mediated and humoral
immune responses for the elimination and containment
of invading microbes [12]. Failure of immune system to
recognize invading pathogens at early stage, favours the
unrestricted growth of microbes, which leads to poten-
tially life threatening complications for the host. MIF
(Macrophage migration inhibitory factor) is an im-
portant cytokine of host antimicrobial defense system,
constitutively expresses with various other cytokines and
promotes pro-inflammatory functions in both innate
and acquired immunity [12,13]. MIF is produced mainly
by T-cells as well as by monocytes, macrophages, den-
dritic cells, B cells, neutrophils and pituitary cells [14].
Conservation of MIF across species (chicken, fish, ticks,
parasites, cyanobacteria and even in Arabidopsis) indi-
cate its important biological functions [13]. Studies have
documented the role of MIF in phosphorylation and
activation of ERK1-ERK2-MAPK pathway (Extracellu-
lar-signal regulated kinase, Mitogen-activated protein
kinase), cell proliferation, up-regulation of TLR4 ex-
pression and suppression of p53 and JAB1 (JUN-activa-
tion domain-binding protein 1) activity [15-20]. It has
been suggested that MIF regulates pro-inflammatory
innate immune response by up regulating the expres-
sion of TLR4 and suppressing the p53 activity and hence
the prolonged cell survival [16,17,19].
Genetic variations in MIF have been shown to be asso-
ciated with many infectious diseases, such as; sarcoidosis,
malaria, schistosomiasis, trypanosomiasis, and leishma-
niasis as well as inflammatory autoimmune diseases in-
cluding rheumatoid arthritis, ulcerative colitis and atopy
[12,14,21-28]. Two variations in the promoter region of
MIF: -173G/C and −794(CATT) STR (short tandem repeat)
regulate the expression of MIF and hence the serum
level and disease susceptibility. In particular, allele -173C
and higher CATT repeats (>5) are associated with higher
MIF production [29-31], however, opposite patterns has
also been reported in different populations, diseases and
even cell types [32-34]. Studies on Zambian children
with malaria demonstrated that higher CATT repeats
(−794CATT*6/7/8) were correlated with increased para-
sitaemia, whereas -794CATT*5 was correlated with de-
crease in parasitaemia [35]. In line to this finding, study
on Kenyan children demonstrated that higher STR re-
peats −794(CATT)7-8 and -173G were associated with
increased risk of severe malarial anaemia [32].
Non-coding RNA (ncRNA) acts as a key regulator of
cellular homeostasis and modulates gene regulation (both
in cis and trans), genome defense as well as chromosomal
modifications. LOC284889 is an uncharacterized genelocated on the reverse strand to MIF mapped to genomic
location 22q11.23. GRCh37/hg19 assembly of UCSC [36]
and NCBI [37] have described it as an ncRNA gene while
ensembl [38] as a putative protein coding. Dysregulations
of ncRNA have been shown to involved in tumorigenesis;
neurological, cardiovascular, developmental as well as
various diseases [39-42].
In addition, several studies have demonstrated the func-
tional significance of MIF gene polymorphism with malaria
severity and pathogenesis in different ethnic populations
across the globe [25,32,43-47]. However, to the best of
knowledge no studies have documented the role of MIF
gene polymorphism to the development of malaria in In-
dian populations. Study on Indian population is interesting
as they have unique genetic makeup compared to rest of
the world. Indian populations remain isolated for thousands
of years hence accumulated unique set of mutations, which
regulate the pathogenesis differently [8,9,48,49]. Therefore,
objective of this study was to investigate the probable asso-
ciation of genetic variations in uncharacterized ncRNA
gene LOC284889 and MIF with Plasmodium falciparum
malaria in well-characterized case–control groups.
Methods
Study subjects and sampling
This study consisted, a total of 425 malaria patients,
which includes severe malaria (160), mild malaria (101)
and asymptomatic control (164) (Table 1). About 5 ml
of intra-venous blood samples were collected from the
patients visiting/admitted for treatment for malaria at
Ispat General Hospital, Rourkela, Orissa State and Pt.
Jawaharlal Nehru Memorial Medical College, Raipur,
Chhattisgarh State, India. These two states are among
the Plasmodium falciparum endemic regions of India
having similar climatic conditions. All individuals re-
presenting the malaria cohort were clinically charac-
terized as per WHO guidelines [50] and as described
previously [8,9]. Samples were Plasmodium falciparum
positive and the microscopic result were re-validated by
polymerase chain reaction (PCR) using species specific-
primers; targeting conserved 18S rRNA gene of the
parasite [51]. Ethnically matched asymptomatic control
samples were collected from the same malaria endemic
region. The controls were not having any clinical symp-
toms at the time of sampling. Blood samples were
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long-term follow-up.
Consent and ethical committee approval
An informed written consent was obtained from all the
individuals. The study was approved by the Institutional
Ethical Committee (IEC) of Centre for Cellular and
Molecular Biology, Hyderabad, India; Ispat General Hos-
pital, Rourkela, Orissa, India; and Pt. Jawaharlal Nehru
Memorial Medical College, Raipur, Chhattisgarh, India.
Genomic DNA isolation and primer designing
Genomic DNA was extracted from whole blood using the
protocol described previously [52]. The reference se-
quence was retrieved from ENSEMBL [38]. Target specific
primer pairs were designed using the Primer-BLAST [53],
MacVector and the Amplify 3X software [54].
Gene sequencing
The 3 kb of target DNA including 1 kb each of upstream
and downstream region was PCR amplified. The primer
pairs used for the amplification have been given in
Table 2. Amplifications were performed using Takara
EmeraldAmp GT PCR kit on GeneAmp 9700 (Applied
Biosystem) and Thermal Cycler (Eppendorf ) following
manufacturer’s protocol. Thermal cycling parameters
for amplification were: initial denaturation at 94°C for
5 minute, followed by 35 cycles of 30 second at 94°C,
25 second at 62 - 67°C (Table 2) and 1 minute 30 second
at 72°C for extension, followed by a final extension of
5 minute at 72°C. PCR products were cleaned up using
2 μl of Exo-SAP (USB, Affymetrix) to 5 μl of PCR pro-
duct, incubating at 37°C for 20 minute followed by
enzyme deactivation at 80°C for 15 minutes. After Exo-
Sap treatment, 1 μl of the purified products were used
as templates for sequencing, using the Big-Dye termi-
nator (v. 3.1) cycle sequencing kit (Applied Bio systems)Table 2 Primer sequences and conditions for the PCR of the M
PCR set Primer locations Primer sequences (5′ - 3′)
SET 1 MIF-F (−1202) GAGCAGTGGACACTCAGTCAG
MIF-R (−647) CCTCTGGGCAACTTCAGCTCCT
SET 2 MIF-F (−740) GCACCTGCTAGATGGTCCCCG
MIF-R (−86) AGTGGGGAAGTCACCGCCTG
SET 3 MIF-F (−315) TTCATCTCTGGAAGGGTAAGG
MIF-R(+1009) GACACTGGGGCTCCTCTGTTAG
MIF-Internal AGTGGTGTCCGAGAAGTCAG
SET 4 MIF-F (+747) TAAGAGCCGCAGGGACCCAC
MIF-R (+1302) TGGCAGTGAGTGGCTCTGGG
SET 5 MIF-F (+1182) GGGAGGAGGAGTTGGAGTTGG
MIF-R (+1757) CCCTGGAGCTTCTATTCTCCTT
Primer locations are relative to transcription start site.on an ABI 3730XL DNA sequencer, according to the
manufacturer’s instructions. Sequencing was done with
a total of five sets of primers as listed in Table 2. DNA
variations were identified after assembling with the
reference sequence using Auto-Assembler software
(Applied Bio system). Observed variations were vali-
dated by re-sequencing in a subset of samples.
Statistical analysis
Allele and genotype frequencies were analysed by simple
gene counting and expectation-maximum (EM) algorithm
and the significance of deviations from Hardy-Weinberg
equilibrium was tested using plink v1.7 [55]. The allele
and genotype distribution and test of association were
performed using plink v1.7. Fisher’s two tailed exact test
and logistic regression were performed by SPSS software
(ver. 20). Linkage disequilibrium (LD) analysis was per-
formed using Haploview v4.2 software [56]. Chi-square
contingency-table test results were interpreted by stan-
dardized residual method of post-hoc analysis [57]. The
haplotype-based association test for multiallelic markers
was performed using WHAP v2.09 package [58]. In all
analysis, a two tailed p-value less than 0.05 were consi-
dered significant.
Results
MIF variations and P. falciparum malaria
Sequencing of MIF gene along with 1 kb each of up-
stream and downstream lead to detection of a total of
nine single nucleotide polymorphism (SNPs) and one
STR CATT repeat at −794 position (Additional file 1).
All the variations were in Hardy Weinberg equilibrium.
Genomic context of MIF and LOC284889 along with ob-
served variations and their genomic coordinates as per
Ensembl Grch37 [38] and NCBI [37] have been shown
in Figure 1. The LD pattern of these variations was
stronger in asymptomatic and mild groups compared toIF gene
Annealing temperature (°C) PCR product size
C
65 600 bp
65 696 bp
GG
62 1370 bpG
67 596 bp
G
65 600 bp
CCT
Figure 1 Genomic map of MIF and ncRNA gene LOC284889. The genomic coordinates are as per ensembl genomic assembly GRCh37. The
observed variations have been placed proportionately on the map.
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the -794CATT STR have been reported [24,32], this
study observed only three alleles [(CATT)5, (CATT)6
and (CATT)7] in Indian population. Previous studies
have demonstrated that the increase in the CATTFigure 2 Linkage Disequilibrium pattern of MIF variants in asymptom
degree of LD (D’ = 1). Numbers indicate the D’ value expressed as a percenrepeats beyond five lead to the increase in MIF level
[24,29]. Therefore, further analysis was done by down-
coding the tri-allelic STR polymorphism as a biallelic:
(1) (CATT)5 and (2) (CATT)6-7; by pooling (CATT)6
and (CATT)7 as one group (> 5 repeat). The distributionatic, mild and severe malaria groups. Empty squares indicate a high
tile.
Figure 3 Distribution of MIF -794CATT STR repeats in case–control groups. A. Genotype and B. allele.
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(asymptomatic, mild and severe malarial cases) has been
summarized in Additional file 1. The genotype and allele
frequencies of CATT repeat at −794 (rs145871794) dif-
fered significantly between severe malaria and asymp-
tomatic control (genotype: χ22 = 7.24, p = 0.02; allele:
χ21 = 6.59, p = 0.01, OR = 0.62, 95% CI = 0.43 - 0.89). How-
ever, in present study, no statistically significant dif-
ferences were observed either in genotype frequency
distribution (χ22 = 2.78, p = 0.2) or in allele frequency
distribution (χ21 = 1.53, p = 0.2, OR = 0.77 95% CI =
0.52 - 1.26) between asymptomatic and mild malaria
(Additional file 1).
ncRNA (LOC284889) gene polymorphism rs34383331 and
P. falciparum malaria
An uncharacterized ncRNA gene (LOC284889) exists on
the opposite strand to MIF (Figure 1). A T >A trans-
version (rs34383331) was observed in ncRNA within 1 kb
downstream region of MIF. The genotype frequency ofTable 3 Comparison of MIF -794CATT STR genotype and allele
Genotype Asymptomatic (n = 164) Mild (n = 101) Severe (n = 160)
−794 CATT
5/5 20 (12.1) 6 (5.9) 7 (4.4)
5/6 54 (32.9) 36 (35.6) 50 (31.2)
6/6 72 (43.9) 48 (42.5) 78 (48.7)
6/7 17 (10.3) 10 (9.9) 24 (15.0)
7/7 1 (0.6) 1 (0.9) 1 (0.6)
Allele Asymptomatic (n = 328) Mild (n = 202) Severe (n = 320)
5 94 (28.5) 48 (23.7) 64 (20.0)
6 215 (65.5) 142 (70.2) 230 (71.9)
7 19 (5.79) 12 (5.9) 26 (8.1)
grouped
5 94 (28.5) 48 (23.7) 64 (20.0)
> 5 234 (71.3) 154 (76.2) 256(80.0)
NS: Not Significant; # Fisher’s two tailed exact test; Values in parenthesis have beenthe observed variation rs34383331 differed signifi-
cantly among the case–control groups (severe: χ22 = 8.6,
p = 0.0133; mild: χ22 = 8.6, p = 0.0133). The allele fre-
quency also differed significantly among these groups
(severe: OR = 2.076, 95% CI = 1.30 – 3.32, p = 0.002;
mild: OR = 2.078, 95% CI = 1.24 – 3.48, p = 0.005)
(Additional file 1). The post-hoc analysis of chi-square
contingency table showed over-representation of genotype
TT (82.9%, z-score = 3.3) and under-representation of geno-
type TA in asymptomatic group (15.2%, z-score = −2.9)
compared to both severe and mild malaria groups. These
findings assign a protective role to T allele.
MIF-794 CATT repeat length polymorphism and malaria
severity
Further, investigation showed the association bet-
ween -794CATT tetra-nucleotide repeats number variation
and malaria severity. The -794CATT genotypes (CATT*5/5,
CATT*5/6, CATT*6/6, CATT*6/7, and CATT*7/7) fre-
quency distributions and statistical comparisons have beenfrequencies among case–control groups
Asymptomatic vs. mild malaria# Asymptomatic vs. severe malaria#
P-value OR (95% CI) P-value OR (95% CI)
NS — 0.015 0.33 (0.13 – 0.80)
NS — NS —
NS — NS —
NS — NS —
NS — NS —
P-value OR (95% CI) P-value OR (95% CI)
NS — 0.011 0.62 (0.43 – 0.89)
NS — NS —
NS — NS —
NS 0.01 0.62 (0.43 – 0.89)
NS — 0.01 1.61 (1.12 – 2.31)
rounded off.
Figure 4 Odds of developing severe malaria per unit rise of (CATT) repeats. The malaria severity increases exponentially following the trend
loge(severity) = [−3.45 + (0.3 ± 0.13) (number of CATT)] [Trend line: logit(P) = loge(odds) = loge(p/q) = a + bX].
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type -794CATT*5/5 was significantly lower in severe
malaria (OR = 0.33, 95% CI = 0.13 – 0.80, p = 0.015),
however, there were no significant difference between
mild malaria and asymptomatic control. The allelic dis-
tribution show that the allele -794CATT*5 was signifi-
cantly under represented in severe malaria (OR = 0.62,
95% CI = 0.43 – 0.89, p = 0.011). In line of these find-
ings, higher CATT repeats (CATT*6/*7) were observed
significantly higher in severe malaria group (OR = 1.61,
95% CI = 1.12 – 2.31, p = 0.01) inferring higher number
of CATT repeat (CATT*6/*7) influence the susceptibility
to malaria (Table 3). The logistic regression analysis show
the severity of malaria increases exponentially with per
unit rise of CATT repeats (χ21 = 4.76, p = 0.029, OR = 1.34,
95% CI = 1.03 – 1.75) (Figure 4).
Diplotype (−794CATT and rs34383331T > A) and malaria
severity
Earlier studies demonstrated that the MIF serum level is
modulated by two promoter polymorphisms -794CATT
and -173G/C [24,29,32]. However, this study did notTable 4 Distribution and comparison of MIF diplotypes (MIF -
Haplotype Asymptomatic (%)
(Total = 328)
Mild (%)
(Total = 202)
Severe
(Total =
MIF-794 and rs34383331
6 T 202 (61.6) 122 (60.4) 194 (60
5 T 90 (27.4) 42 (20.8) 55 (17.2
7A 14 (4.3) 10 (4.9) 12 (3.7)
6A 13 (4) 20 (9.9) 36 (11.2
7 T 5 (1.5) 2 (1) 14 (4.4)
5A 4 (1.2) 6 (2.97) 9 (2.8)
NS Not Significant, *Fisher’s two tailed exact test; Values in parenthesis have been rounobserve any association with -173G/C. Instead, downstream
polymorphism rs34383331 T>A observed in ncRNA was
associated significantly with malaria. Therefore, these two
variations (−794CATT and rs34383331T > A) were consid-
ered for diplotype reconstruction and analysed for their
possible association with malaria (Table 4). The diplotype
6A was observed significantly higher in mild malaria
group (OR = 2.66, 95% CI = 1.29 – 5.48, p = 0.018)
[Bonferroni corrected p-value] compared to asymptomatic
control. However, diplotype 5 T was significantly lower
(OR = 0.55, 95% CI = 0.38 – 0.80, p = 0.002), while
diplotype 6A (OR = 3.07, 95% CI = 1.59 – 5.91, p = 0.002)
[Bonferroni corrected p-value] was significantly higher in
severe malaria compared to the asymptomatic control
(Table 4).
Discussion
Genetic variations play an important role in the occur-
rence and development of malaria and its severity. Varia-
tions in several host genes (HBB, IL4, IL12, TNF, LTA,
NCR3 and FCGR2A) have been reported to be associated
with malaria outcome [59]. Therefore, studies on794CATT and rs34383331T > A) in case–control groups
(%)
320)
Asymptomatic* vs. mild
malaria
Asymptomatic* vs. severe
malaria
P - value OR (95% CI) P - value OR (95% CI)
.6) NS — NS —
) NS — 0.002 0.55 (0.38 – 0.80)
NS — NS —
) 0.018 2.66 (1.29 – 5.48) 0.002 3.07 (1.59 – 5.91)
NS — NS —
NS — NS —
ded off; P - value was corrected for multiple comparisons by Bonferroni’s method.
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susceptibility are of greater interest in the prevention
and control of malaria.
MIF is a lymphokine involved in cell-mediated
immunity, immune-regulation, and inflammation. MIF
plays a role in the regulation of macrophage function
in host defense through the suppression of anti-
inflammatory effects of glucocorticoids. Further, MIF
regulates pro-inflammatory innate immune response
by up-regulating the expression of TLR4 and sup-
pressing the p53 activity [16,17,19]. Several studies
have shown that the MIF genetic variants regulate the
MIF serum levels in various diseases, such as; sarcoid-
osis, malaria, schistosomiasis, trypanosomiasis, leish-
maniasis, rheumatoid arthritis, ulcerative colitis and
atopy [12,14,21-28]. Further, its clinical significance
also varies in different populations [25,32,43-47]. Ad-
ditionally, studies have documented that two MIF pro-
moter polymorphism -794CATT repeat and -173G/C
regulates the level of MIF expression and alter the
serum level of MIF; particulary an increase in number
of -794CATT STR repeats lead to elevated levels of
MIF expression [29-31]. Studies on Indian populations
have shown association between elevated level of MIF
in the peripheral blood of cerebral malarial with the
fatal outcome [47]. A recent study also has demonstrated
association between elevated level of inter-villous MIF
level with still birth and low birth deliveries in Central In-
dian population [60]. However, both of these studies
have not looked into the MIF polymorphism. To the
best of the knowledge, no study to date has investigated
the association of MIF polymorphism with malarial sus-
ceptibility in Indian populations. Therefore, this study
investigated the possible association between MIF gene
polymorphism and P. falciparum malaria outcome in a
well-defined ethnically matched case–control cohort
from Orissa and Chhattisgarh, the malaria endemic
states of India.
The present study observed significant difference in
genotype and allele distribution of MIF gene among
ethnically matched case–control groups. The CATT*5
was significantly higher in asymptomatic control, while
CATT*6 and CATT*7 were significantly higher in
malaria groups suggesting that the higher repeat as the
risk factor to severe malaria in Indian populations. This
finding is in agreement with the earlier studies, which
have demonstrated that higher repeats increases sus-
ceptibility to malaria [29,32,35,47]. Previous study has
demonstrated that the expansion of -794CATT repeat is
directly proportionate to the severity of malaria among
the children of Zambia and Kenya [32,35]. Although the
present study shows the association of higher -794CATT
repeats with the severity of malaria in Indian adults,
similar association in children cannot be ignored.Further, earlier study has also documented a strong
LD between -794CATT repeat and -173G/C as well as
association of -173G/C with severe malarial anaemia in
African populations [32]. However, this study did not
observe strong LD between these two promoter poly-
morphisms (Figure 2). In addition, -173G/C also did
not show any association with malaria in Indian popu-
lation. This observations is not surprising as similar
heterogeneity have been observed among Indian popu-
lations due to their unique genetic architecture and
they show varied response to pathogen and other
diseases [8,9,48,49].
Interestingly, this is the first study which shows that
the genotype and allele distribution of rs34383331T > A,
present in an uncharacterized ncRNA (LOC284889) and
located on the reverse strand to MIF, differ significantly
between malaria cases and asymptomatic control groups.
Further, this SNP is in strong LD with promoter as well as
ORF variants in asymptomatic and mild malaria group
compared to the severe malaria group. The genotype TT
was significantly higher while genotype TA was signifi-
cantly lower in asymptomatic control compared to malaria
groups, which assigns a protective role of allele T against
malaria.
Further, the diplotype reconstruction of promoter
variant -794CATT and ncRNA variant rs34383331 T>A
show that the diplotype 5 T is significantly lower in se-
vere malaria, while 6A were higher in severe malaria
compared to asymptomatic control. This again eluci-
dates that the individuals with additional CATT repeat
and allele A have high risk for malaria.
Conclusions
In conclusion, for the first time, this study reports
the association of an ncRNA with malaria pathoge-
nesis. In addition, this study also observed that the
MIF polymorphism is associated with malaria patho-
genesis in Orissa and Chhattisgarh populations of
India. These findings, which show the involvement of
ncRNA along with previous studies on IL4 and IFNB
[8,9], further emphasize the complex genetic regula-
tion of malaria outcome. Genotyping this polymor-
phism in further larger case–control and cohort
studies as well as on ethnically different populations
is strongly recommended for the better estimation of
malaria risk associated with this polymorphism. This
study also emphasizes the role of host genetics in
modulating pathogenesis and disease outcome. As
the malaria severity is the outcome of complex ge-
netic interplay; numerous variants are likely to act in
tandem. Therefore, the studies of down-stream as
well as other immune-regulator genes are equally im-
portant to understand the molecular basis of disease
severity.
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